LSTA icon

Lisata Therapeutics
LSTA

Overview Fund Trends Analyst Outlook Journalist POV

22 hedge funds and large institutions have $2.51M invested in Lisata Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.4% more ownership

Funds ownership: 8.14% → 8.54% (+0.4%)

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$63.6K
2
+$46.5K
3
+$37K
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.33K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.36K

Top Sellers

1
-$26
2
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$902K
2
$652K
3
$345K
4
$210K
5
$96.1K
6
$63.6K
7
$55.3K
8
$53.1K
9
$52.3K
10
$38.4K
11
$37K
12
$3.92K
13
$2.46K
14
$1K
15
$115
16
$96
17
$74
18
$4
19
$4
20
$3
21
–